Creative Antibiotics AB (OSTO:CAS) Equity-to-Asset : -0.13 (As of Mar. 2013)

View and export this data going back to . Start your Free Trial

What is Creative Antibiotics AB Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Creative Antibiotics AB's Total Stockholders Equity for the quarter that ended in Mar. 2013 was kr-1.31 Mil. Creative Antibiotics AB's Total Assets for the quarter that ended in Mar. 2013 was kr9.91 Mil.

The historical rank and industry rank for Creative Antibiotics AB's Equity-to-Asset or its related term are showing as below:

OSTO:CAS's Equity-to-Asset is not ranked ^*
in the industry.
Industry Median:
* Ranked among companies with meaningful Equity-to-Asset only.

Creative Antibiotics AB Equity-to-Asset Historical Data

The historical data trend for Creative Antibiotics AB's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creative Antibiotics AB Equity-to-Asset Chart

Creative Antibiotics AB Annual Data

Trend

Jun08

Jun09

Jun10

Dec11

Equity-to-Asset

0.70

0.47

0.84

0.61

Creative Antibiotics AB Quarterly Data
	Jun08	Mar09	Jun09	Sep09	Dec09	Mar10	Sep10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Mar13
Equity-to-Asset	Get a 7-Day Free Trial										0.61	0.54	0.40	0.32	-0.13

Competitive Comparison of Creative Antibiotics AB's Equity-to-Asset

For the subindustry, Creative Antibiotics AB's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Creative Antibiotics AB's Equity-to-Asset Distribution in the Industry

For the industry and sector, Creative Antibiotics AB's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Creative Antibiotics AB's Equity-to-Asset falls into.

Creative Antibiotics AB Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Creative Antibiotics AB's Equity to Asset Ratio for the fiscal year that ended in Dec. 2011 is calculated as

Equity to Asset (A: Dec. 2011 )	=	Total Stockholders Equity	/	Total Assets
	=	17.788	/	29.151
	=

Creative Antibiotics AB's Equity to Asset Ratio for the quarter that ended in Mar. 2013 is calculated as

Equity to Asset (Q: Mar. 2013 )	=	Total Stockholders Equity	/	Total Assets
	=	-1.31	/	9.908
	=

Creative Antibiotics AB (OSTO:CAS) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Creative Antibiotics AB Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Creative Antibiotics AB's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.